-
That's what one paramedic says of the targeting of ambulance crews. Criminals are after phones and wallets along with medical equipment and drugs. We ride along with a Cape Town crew in a Red Zone.
-
Samples of Beethoven's hair reveal he may have suffered from lead poisoning, which could explain some of the difficult physical maladies the composer suffered in his life.
-
AI can conjure the voice or likeness of a dead celebrity with just a few clicks. This opens a host of legal questions about the rights of the deceased and their heirs to control their digital replicas
-
Two new studies show fentanyl smuggling has increased dramatically despite efforts to target the cartels and tighten border security.
-
Stanford students on a hackathon team have created an AI tool designed to help veterans apply for disability benefits. Can their tool beat the Department of Veteran Affairs' notorious red tape?
-
Ukraine struggles to repel a Russian offensive along the northeastern border. President Biden is to announce new tariffs on Chinese imports. Gangs from China and Mexico flood U. S. with fentanyl.
-
A Jesus made of vegetables, bizarre log cabins, products that don't exist. AI-generated images are creating new forms of clickbait and causing some users to doubt what's real.
-
When Thorsten Siess was in graduate school, he came up with the idea for a heart device that's now been used in hundreds of thousands of patients around the world.
-
At the European Hospital in Rafah, there are shortages of pain medication, antibiotics, even bandages. American volunteers say they are unable to save lives — and unable to evacuate to safety.
-
Complex patients who need long-term care are struggling to find care in skilled nursing facilities. Researchers say staffing shortages play a huge role.
-
Two new reports show the fentanyl crisis isn't easing, as drug cartels continue to flood U.S. communities with the deadly illicit opioid often disguised as fake prescription pills.
-
Clinical trials of MDMA have been promising, but concerns have emerged about the quality of the research. A June hearing scheduled by the Food and Drug Administration is likely to address them.